Skip to main content
. 2024 Oct 2;17:194. doi: 10.1186/s13048-024-01520-2

Fig. 3.

Fig. 3

Drug testing and personalized therapy of ovarian cancer in OV-PDOs. Dose–response curves of 10 OV-PDOs treated with cisplatin, carboplatin, paclitaxel, gemcitabine, epirubicin, doxorubicin, topotecan, and olaparib. Dots represent five-repetition means. Error bars represent five-repetition standard error of the mean. The statistical analysis of drug response at 0.1 µM was calculated using the chi-square test